カテゴリ： 世界, 医療/バイオ, QYResearch

地図状萎縮治療の世界市場インサイト・予測（～2028年）

■ 英語タイトル：Global Geographic Atrophy Treatment Market Insights, Forecast to 2028

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QY22JL3463）■ 発行会社/調査会社：QYResearch
■ 商品コード：QY22JL3463
■ 発行日：2022年7月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：110
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[地図状萎縮治療の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

COVID-19のパンデミックにより、地図状萎縮治療のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に地図状萎縮治療の世界市場のxxx％を占める「後期（フェーズIII）治療」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
地図状萎縮治療の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの地図状萎縮治療市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

地図状萎縮治療のグローバル主要企業には、Apellis Pharmaceuticals、IVERIC bio、Alkeus Pharmaceuticals、Hemera Biosciences、Allegro Ophthalmics、Stealth BioTherapeutics、Gyroscope Therapeutics、Regenerative Patch Technologies、Roche Holding AG、Gensight Biologics SA、NGM Biopharmaceuticals、AstraZeneca、Lineage Cell Therapeutics、Allerganなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

地図状萎縮治療市場は、種類と用途によって区分されます。世界の地図状萎縮治療市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
後期（フェーズIII）治療、フェーズII治療、フェーズI治療、前臨床段階治療

【用途別セグメント】
病院、クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 地図状萎縮治療製品概要
- 種類別市場（後期（フェーズIII）治療、フェーズII治療、フェーズI治療、前臨床段階治療）
- 用途別市場（病院、クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の地図状萎縮治療販売量予測2017-2028
- 世界の地図状萎縮治療売上予測2017-2028
- 地図状萎縮治療の地域別販売量
- 地図状萎縮治療の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別地図状萎縮治療販売量
- 主要メーカー別地図状萎縮治療売上
- 主要メーカー別地図状萎縮治療価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（後期（フェーズIII）治療、フェーズII治療、フェーズI治療、前臨床段階治療）
- 地図状萎縮治療の種類別販売量
- 地図状萎縮治療の種類別売上
- 地図状萎縮治療の種類別価格
・用途別市場規模（病院、クリニック）
- 地図状萎縮治療の用途別販売量
- 地図状萎縮治療の用途別売上
- 地図状萎縮治療の用途別価格
・北米市場
- 北米の地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの地図状萎縮治療市場規模（種類別、用途別）
- 主要国別の地図状萎縮治療市場規模（トルコ、サウジアラビア）
・企業情報
Apellis Pharmaceuticals、IVERIC bio、Alkeus Pharmaceuticals、Hemera Biosciences、Allegro Ophthalmics、Stealth BioTherapeutics、Gyroscope Therapeutics、Regenerative Patch Technologies、Roche Holding AG、Gensight Biologics SA、NGM Biopharmaceuticals、AstraZeneca、Lineage Cell Therapeutics、Allergan
・産業チェーン及び販売チャネル分析
- 地図状萎縮治療の産業チェーン分析
- 地図状萎縮治療の原材料
- 地図状萎縮治療の生産プロセス
- 地図状萎縮治療の販売及びマーケティング
- 地図状萎縮治療の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 地図状萎縮治療の産業動向
- 地図状萎縮治療のマーケットドライバー
- 地図状萎縮治療の課題
- 地図状萎縮治療の阻害要因
・主な調査結果

Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) that causes a continuous progressive degeneration of the macula. The condition is characterized by widespread atrophy of the outer retinal tissue, retinal pigment epithelium, and choriocapillaris. It typically starts in the perifoveal region and develops to the fovea over time and causing central scotomas and permanent vision loss. Various drugs and treatments are under evaluation.
Market Analysis and Insights: Global Geographic Atrophy Treatment Market
The global Geographic Atrophy Treatment market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Late-stage (Phase III) Treatment accounting for % of the Geographic Atrophy Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Geographic Atrophy Treatment market size is valued at US$ million in 2021, while the North America and Europe Geographic Atrophy Treatment are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Geographic Atrophy Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Geographic Atrophy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Geographic Atrophy Treatment market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Geographic Atrophy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Geographic Atrophy Treatment market.
Global Geographic Atrophy Treatment Scope and Market Size
Geographic Atrophy Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Geographic Atrophy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Late-stage (Phase III) Treatment
Phase II Treatment
Phase I Treatment
Pre-Clinical Stage Treatment
Segment by Application
Hospital
Clinic
By Company
Apellis Pharmaceuticals
IVERIC bio
Alkeus Pharmaceuticals
Hemera Biosciences
Allegro Ophthalmics
Stealth BioTherapeutics
Gyroscope Therapeutics
Regenerative Patch Technologies
Roche Holding AG
Gensight Biologics SA
NGM Biopharmaceuticals
AstraZeneca
Lineage Cell Therapeutics
Allergan
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

*** レポート目次（コンテンツ）***

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Late-stage (Phase III) Treatment
1.2.3 Phase II Treatment
1.2.4 Phase I Treatment
1.2.5 Pre-Clinical Stage Treatment
1.3 Market by Application
1.3.1 Global Geographic Atrophy Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Geographic Atrophy Treatment Market Perspective (2017-2028)
2.2 Geographic Atrophy Treatment Growth Trends by Region
2.2.1 Geographic Atrophy Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Geographic Atrophy Treatment Historic Market Size by Region (2017-2022)
2.2.3 Geographic Atrophy Treatment Forecasted Market Size by Region (2023-2028)
2.3 Geographic Atrophy Treatment Market Dynamics
2.3.1 Geographic Atrophy Treatment Industry Trends
2.3.2 Geographic Atrophy Treatment Market Drivers
2.3.3 Geographic Atrophy Treatment Market Challenges
2.3.4 Geographic Atrophy Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Geographic Atrophy Treatment Players by Revenue
3.1.1 Global Top Geographic Atrophy Treatment Players by Revenue (2017-2022)
3.1.2 Global Geographic Atrophy Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Geographic Atrophy Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Geographic Atrophy Treatment Revenue
3.4 Global Geographic Atrophy Treatment Market Concentration Ratio
3.4.1 Global Geographic Atrophy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geographic Atrophy Treatment Revenue in 2021
3.5 Geographic Atrophy Treatment Key Players Head office and Area Served
3.6 Key Players Geographic Atrophy Treatment Product Solution and Service
3.7 Date of Enter into Geographic Atrophy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Geographic Atrophy Treatment Breakdown Data by Type
4.1 Global Geographic Atrophy Treatment Historic Market Size by Type (2017-2022)
4.2 Global Geographic Atrophy Treatment Forecasted Market Size by Type (2023-2028)
5 Geographic Atrophy Treatment Breakdown Data by Application
5.1 Global Geographic Atrophy Treatment Historic Market Size by Application (2017-2022)
5.2 Global Geographic Atrophy Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Geographic Atrophy Treatment Market Size (2017-2028)
6.2 North America Geographic Atrophy Treatment Market Size by Type
6.2.1 North America Geographic Atrophy Treatment Market Size by Type (2017-2022)
6.2.2 North America Geographic Atrophy Treatment Market Size by Type (2023-2028)
6.2.3 North America Geographic Atrophy Treatment Market Share by Type (2017-2028)
6.3 North America Geographic Atrophy Treatment Market Size by Application
6.3.1 North America Geographic Atrophy Treatment Market Size by Application (2017-2022)
6.3.2 North America Geographic Atrophy Treatment Market Size by Application (2023-2028)
6.3.3 North America Geographic Atrophy Treatment Market Share by Application (2017-2028)
6.4 North America Geographic Atrophy Treatment Market Size by Country
6.4.1 North America Geographic Atrophy Treatment Market Size by Country (2017-2022)
6.4.2 North America Geographic Atrophy Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Geographic Atrophy Treatment Market Size (2017-2028)
7.2 Europe Geographic Atrophy Treatment Market Size by Type
7.2.1 Europe Geographic Atrophy Treatment Market Size by Type (2017-2022)
7.2.2 Europe Geographic Atrophy Treatment Market Size by Type (2023-2028)
7.2.3 Europe Geographic Atrophy Treatment Market Share by Type (2017-2028)
7.3 Europe Geographic Atrophy Treatment Market Size by Application
7.3.1 Europe Geographic Atrophy Treatment Market Size by Application (2017-2022)
7.3.2 Europe Geographic Atrophy Treatment Market Size by Application (2023-2028)
7.3.3 Europe Geographic Atrophy Treatment Market Share by Application (2017-2028)
7.4 Europe Geographic Atrophy Treatment Market Size by Country
7.4.1 Europe Geographic Atrophy Treatment Market Size by Country (2017-2022)
7.4.2 Europe Geographic Atrophy Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Geographic Atrophy Treatment Market Size (2017-2028)
8.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Type
8.2.1 Asia-Pacific Geographic Atrophy Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Geographic Atrophy Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Geographic Atrophy Treatment Market Size by Application
8.3.1 Asia-Pacific Geographic Atrophy Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Geographic Atrophy Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Geographic Atrophy Treatment Market Size by Region
8.4.1 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Geographic Atrophy Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Geographic Atrophy Treatment Market Size (2017-2028)
9.2 Latin America Geographic Atrophy Treatment Market Size by Type
9.2.1 Latin America Geographic Atrophy Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Geographic Atrophy Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Geographic Atrophy Treatment Market Share by Type (2017-2028)
9.3 Latin America Geographic Atrophy Treatment Market Size by Application
9.3.1 Latin America Geographic Atrophy Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Geographic Atrophy Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Geographic Atrophy Treatment Market Share by Application (2017-2028)
9.4 Latin America Geographic Atrophy Treatment Market Size by Country
9.4.1 Latin America Geographic Atrophy Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Geographic Atrophy Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Geographic Atrophy Treatment Market Size (2017-2028)
10.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type
10.2.1 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Geographic Atrophy Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Geographic Atrophy Treatment Market Size by Application
10.3.1 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Geographic Atrophy Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Geographic Atrophy Treatment Market Size by Country
10.4.1 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Geographic Atrophy Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Apellis Pharmaceuticals
11.1.1 Apellis Pharmaceuticals Company Details
11.1.2 Apellis Pharmaceuticals Business Overview
11.1.3 Apellis Pharmaceuticals Geographic Atrophy Treatment Introduction
11.1.4 Apellis Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.1.5 Apellis Pharmaceuticals Recent Developments
11.2 IVERIC bio
11.2.1 IVERIC bio Company Details
11.2.2 IVERIC bio Business Overview
11.2.3 IVERIC bio Geographic Atrophy Treatment Introduction
11.2.4 IVERIC bio Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.2.5 IVERIC bio Recent Developments
11.3 Alkeus Pharmaceuticals
11.3.1 Alkeus Pharmaceuticals Company Details
11.3.2 Alkeus Pharmaceuticals Business Overview
11.3.3 Alkeus Pharmaceuticals Geographic Atrophy Treatment Introduction
11.3.4 Alkeus Pharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.3.5 Alkeus Pharmaceuticals Recent Developments
11.4 Hemera Biosciences
11.4.1 Hemera Biosciences Company Details
11.4.2 Hemera Biosciences Business Overview
11.4.3 Hemera Biosciences Geographic Atrophy Treatment Introduction
11.4.4 Hemera Biosciences Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.4.5 Hemera Biosciences Recent Developments
11.5 Allegro Ophthalmics
11.5.1 Allegro Ophthalmics Company Details
11.5.2 Allegro Ophthalmics Business Overview
11.5.3 Allegro Ophthalmics Geographic Atrophy Treatment Introduction
11.5.4 Allegro Ophthalmics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.5.5 Allegro Ophthalmics Recent Developments
11.6 Stealth BioTherapeutics
11.6.1 Stealth BioTherapeutics Company Details
11.6.2 Stealth BioTherapeutics Business Overview
11.6.3 Stealth BioTherapeutics Geographic Atrophy Treatment Introduction
11.6.4 Stealth BioTherapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.6.5 Stealth BioTherapeutics Recent Developments
11.7 Gyroscope Therapeutics
11.7.1 Gyroscope Therapeutics Company Details
11.7.2 Gyroscope Therapeutics Business Overview
11.7.3 Gyroscope Therapeutics Geographic Atrophy Treatment Introduction
11.7.4 Gyroscope Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.7.5 Gyroscope Therapeutics Recent Developments
11.8 Regenerative Patch Technologies
11.8.1 Regenerative Patch Technologies Company Details
11.8.2 Regenerative Patch Technologies Business Overview
11.8.3 Regenerative Patch Technologies Geographic Atrophy Treatment Introduction
11.8.4 Regenerative Patch Technologies Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.8.5 Regenerative Patch Technologies Recent Developments
11.9 Roche Holding AG
11.9.1 Roche Holding AG Company Details
11.9.2 Roche Holding AG Business Overview
11.9.3 Roche Holding AG Geographic Atrophy Treatment Introduction
11.9.4 Roche Holding AG Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.9.5 Roche Holding AG Recent Developments
11.10 Gensight Biologics SA
11.10.1 Gensight Biologics SA Company Details
11.10.2 Gensight Biologics SA Business Overview
11.10.3 Gensight Biologics SA Geographic Atrophy Treatment Introduction
11.10.4 Gensight Biologics SA Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.10.5 Gensight Biologics SA Recent Developments
11.11 NGM Biopharmaceuticals
11.11.1 NGM Biopharmaceuticals Company Details
11.11.2 NGM Biopharmaceuticals Business Overview
11.11.3 NGM Biopharmaceuticals Geographic Atrophy Treatment Introduction
11.11.4 NGM Biopharmaceuticals Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.11.5 NGM Biopharmaceuticals Recent Developments
11.12 AstraZeneca
11.12.1 AstraZeneca Company Details
11.12.2 AstraZeneca Business Overview
11.12.3 AstraZeneca Geographic Atrophy Treatment Introduction
11.12.4 AstraZeneca Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.12.5 AstraZeneca Recent Developments
11.13 Lineage Cell Therapeutics
11.13.1 Lineage Cell Therapeutics Company Details
11.13.2 Lineage Cell Therapeutics Business Overview
11.13.3 Lineage Cell Therapeutics Geographic Atrophy Treatment Introduction
11.13.4 Lineage Cell Therapeutics Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.13.5 Lineage Cell Therapeutics Recent Developments
11.14 Allergan
11.14.1 Allergan Company Details
11.14.2 Allergan Business Overview
11.14.3 Allergan Geographic Atrophy Treatment Introduction
11.14.4 Allergan Revenue in Geographic Atrophy Treatment Business (2017-2022)
11.14.5 Allergan Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 脊髄性筋萎縮症治療のグローバル市場（2022年-2029年）：ヌシネルセン、オナセムノゲンアベパルボベク
  • 地図状萎縮の世界市場インサイト・予測（～2028年）
  • 結膜炎治療の世界市場インサイト・予測（～2028年）
  • 脳がん治療の世界市場インサイト・予測（～2028年）
  • 眼がん治療の世界市場インサイト・予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QY22JL3463 )"地図状萎縮治療の世界市場インサイト・予測（～2028年）" (英文：Global Geographic Atrophy Treatment Market Insights, Forecast to 2028)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。